Recent Finacing
Recent Raise
Antabio is a clinical-stage biopharmaceutical company in Labège, France developing antibacterial resistance-breakers, including MBL inhibitor–carbapenem combinations for nosocomial CRAB/CRE and an inhaled Pseudomonas virulence inhibitor for chronic respiratory infections.
